Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Blood Cancer Discovery|September 27, 2021
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationAnnamaria Gulla, Eugenio Morelli, Mehmet K Samur, et al.
Blood|April 13, 2010
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Teru Hideshima, et al.
Nature Communications|January 6, 2016
The KDM3A-KLF2-IRF4 axis maintains myeloma cell survivalHiroto Ohguchi, Teru Hideshima, Manoj K Bhasin, et al.
Cancer Research|August 8, 2015
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple MyelomaJian-Jun Zhao, Zhang-Bo Chu, Yu Hu, et al.
Blood Advances|January 4, 2018
Constitutive Ras signaling and <i>Ink4a/Arf</i> inactivation cooperate during the development of B-ALL in miceTomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2023
In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapyPedro P G Guimarães, Christian G Figueroa-Espada, Rachel S Riley, et al.
Blood Advances|November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cellsTomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
Blood Cancer Discovery|July 16, 2021
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow MicroenvironmentGiada Bianchi, Peter G Czarnecki, Matthew Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myelomaTeru Hideshima, Jun Qi, Ronald M Paranal, et al.
Pageof 5